In an international study, tadalafil (Cialis drug, Eli Lilly) improved erectile function in men with spinal cord injury.
After a four-week run-in period, 186 men (mean, 38 years of age) were randomly assigned to receive ondemand tadalafil or placebo for 12 weeks. The tadalafil dose was maintained at 10 mg/day or was titrated to 20 mg/day.
Most of the patients had had erectile dysfunction (ED) for at least one year; 69% had moderate-to-severe ED. The majority of men (78%) had a neurological injury at or above the T11 level. Yet despite serious baseline conditions, all primary efficacy variables improved significantly with tadalafil treatment improved ED from moderate at baseline to mild.

The use of no-rinse 2% chlorhexidineimpregnated cloths to bathe patients in the medical intensive-care unit has been found to reduce primary bloodstream infections by 61%, compared with soap and water.
